APSR2026-997

Yes
Late-Breaking
Submitted
Poster Presentation
 
AP08-021
P76
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1216165-46904-APSR-997.pdf_440270.pdf
Format: PDF Only
06. Tuberculosis
6

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Disni De Zoysa * National Hospital for Respiratory Diseases Respiratory Medicine Welisara Sri Lanka
Parami Munasinghe - National Hospital for Respiratory Diseases Respiratory Medicine Welisara Sri Lanka
Wathsala Galagedara - National Tuberculosis Reference Laboratory Respiratory Medicine Welisara Sri Lanka
Damith Rodrigo - National Hospital for Respiratory Diseases Respiratory Medicine Welisara Sri Lanka
Saman Kularathne - National Hospital for Respiratory Diseases Respiratory Medicine Welisara Sri Lanka
Bodhika Samarasekera - National Hospital for Respiratory Diseases Respiratory Medicine Welisara Sri Lanka
 
 
 
 
 
 
 
 
 
Presenting Author Details
Disni
De Zoysa
disni.dezoysa04@gmail.com
+94711488957
31-40
Sri Lanka
Original Research
Diagnostic Utility of GeneXpert Ultra MTB/RIF Assay in Pleural Fluid for Suspected Tuberculous Pleural Effusion: A Cross-Sectional Study from Sri Lanka
Maximum 25 words
Abstract Content
Tuberculous pleural effusion (TPE) is the second most common type of extrapulmonary tuberculosis and remains a challenge to diagnose due to its paucibacillary nature. GeneXpert Ultra MTB/RIF offers rapid molecular detection of Mycobacterium tuberculosis and rifampicin resistance. This study evaluated the utility of GeneXpert Ultra in pleural fluid specimens from patients with suspected TPE.
A cross-sectional study was conducted at the National Hospital for Respiratory Diseases, Welisara, Sri Lanka, between January and December 2025. Fifty-seven adults with clinically and radiologically suspected TPE ,a lymphocytic exudative pleural effusion and Adenosine Deaminase (ADA) level more than 40 U/L were included. Pleural fluid samples underwent Ziehl–Neelsen (ZN) staining, GeneXpert Ultra MTB/RIF testing, and Mycobacteria Growth Indicator Tube (MGIT) culture. Demographic, clinical, and microbiological data were analyzed descriptively.
Among 57 participants, 49 (86.0%) were male and the largest age group was 41–60 years (35.1%). Cough and fever were the commonest symptoms, each occurring in 61.4% of patients. All pleural fluid samples were negative on ZN microscopy. GeneXpert Ultra was positive in 14/57 patients (24.6%), while MGIT culture was positive in only 1/57 (1.8%). Among positive GeneXpert results, 11 (78.6%) were trace-positive, two (14.3%) were very low, and one (7.1%) was high. No rifampicin resistance was detected. Of the 14 GeneXpert-positive samples, only one was culture positive, while all GeneXpert-negative samples were culture negative.
GeneXpert Ultra demonstrated a significantly higher detection rate than pleural fluid culture in suspected TPE and identified cases with very low bacillary burden. Although the extremely low culture positivity limited formal diagnostic accuracy analysis, GeneXpert Ultra appears to provide valuable diagnostic support in pleural tuberculosis when interpreted in conjunction with clinical, radiological, and biochemical findings.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Tuberculous pleural effusion, GeneXpert Ultra, extrapulmonary tuberculosis, MGIT culture, Sri Lanka.
maximum 3 keywords and no abbreviations, separated by commas
The authors declare no conflicts of interest.
289